MYGN (STOCKS)
Myriad Genetics Inc
$3.170000
-0.060000 (-1.86%)
Prev close: $3.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Samraat S Raha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $324.29M
- Employees
- 2,700
- P/E (TTM)
- -2.69
- P/B (TTM)
- 1.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
2
Buy
8
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.25 | $-0.06 | -0.1910 | -323.73% |
|
Mar 2026 (Q1)
|
$-0.09 | $-0.07 | -0.0202 | -28.94% |
|
Dec 2025 (Q4)
|
$0.04 | $-0.01 | +0.0549 | +368.46% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.01 | +0.0080 | +100.00% |
Financial Statements
| Revenues | $806.60M |
| Benefits Costs and Expenses | $918.40M |
| Cost Of Revenue | $251.40M |
| Costs And Expenses | $918.40M |
| Gross Profit | $555.20M |
| Nonoperating Income/Loss | -$13.20M |
| Operating Expenses | $653.80M |
| Depreciation and Amortization | $50.20M |
| Research and Development | $105.80M |
| Other Operating Expenses | $522.90M |
| Operating Income/Loss | -$98.60M |
| Income/Loss From Continuing Operations After Tax | -$112.60M |
| Income/Loss From Continuing Operations Before Tax | -$111.80M |
| Income Tax Expense/Benefit | $800.00K |
| Net Income/Loss | -$112.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$112.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$112.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Diluted Earnings Per Share | -$1.18 |
| Basic Average Shares | 187,600,000 |
| Diluted Average Shares | 187,600,000 |
| Assets | $638.90M |
| Current Assets | $289.00M |
| Inventory | $30.60M |
| Other Current Assets | $258.40M |
| Noncurrent Assets | $349.90M |
| Fixed Assets | $108.90M |
| Intangible Assets | $139.00M |
| Other Non-current Assets | $102.00M |
| Liabilities | $335.00M |
| Current Liabilities | $130.70M |
| Accounts Payable | $30.40M |
| Wages | $39.20M |
| Other Current Liabilities | $61.10M |
| Noncurrent Liabilities | $204.30M |
| Long-term Debt | $120.70M |
| Other Non-current Liabilities | $83.60M |
| Equity | $303.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $303.90M |
| Liabilities And Equity | $638.90M |
| Net Cash Flow From Operating Activities | $7.70M |
| Net Cash Flow From Operating Activities, Continuing | $7.70M |
| Net Cash Flow From Investing Activities | -$21.90M |
| Net Cash Flow From Investing Activities, Continuing | -$21.90M |
| Net Cash Flow From Financing Activities | $47.20M |
| Net Cash Flow From Financing Activities, Continuing | $47.20M |
| Exchange Gains/Losses | $100.00K |
| Net Cash Flow | $33.10M |
| Net Cash Flow, Continuing | $33.00M |
| Comprehensive Income/Loss | -$111.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$111.70M |
| Other Comprehensive Income/Loss | -$111.70M |
| Other Comprehensive Income/Loss Attributable To Parent | $900.00K |